MétaCan
Menu
Back to cohort
Record W2608082925 · doi:10.1200/jco.2016.69.4935

Prediction of Breast and Prostate Cancer Risks in Male <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Using Polygenic Risk Scores

2017· article· en· W2608082925 on OpenAlexfundno aff
Julie Lecarpentier, Valentina Silvestri, Karoline Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Penny Soucy, Goska Leslie, Piera Rizzolo, Anna Sara Navazio, Virginia Valentini, Veronica Zelli, Andrew Lee, Ali Amin Al Olama, Jonathan P. Tyrer, Melissa C. Southey, Esther M. John, Thomas Conner, David E. Goldgar, Saundra S. Buys, Ramūnas Janavičius, Linda Steele, Yuan Chun Ding, Susan L. Neuhausen, Thomas van Overeem Hansen, Ana Osório, Jeffrey N. Weitzel, Angela Toss, Veronica Medici, Laura Cortesi, Ines Zanna, Domenico Palli, Paolo Radice, Siranoush Manoukian, Bernard Peissel, Jacopo Azzollini, Alessandra Viel, Giulia Cini, Giuseppe Damante, Stefania Tommasi, Paolo Peterlongo, Florentia Fostira, Ute Hamann, D. Gareth Evans, Alex Henderson, Carole Brewer, Diana Eccles, Jackie Cook, Kai-Ren Ong, Lisa Walker, Lucy Side, Mary Porteous, Rosemarie Davidson, Shirley Hodgson, Debra Frost, Julian Adlard, Louise Izatt, Rosalind A. Eeles, Marc Tischkowitz, Andrew K. Godwin, Alfons Meindl, Andrea Gehrig, Bernd Dworniczak, Christian Sutter, Christoph Engel, Dieter Niederacher, Doris Steinemann, Jan Hauke, Kerstin Rhiem, Karin Kast, Norbert Arnold, Nina Ditsch, Shan Wang‐Gohrke, Barbara Wappenschmidt, Dorothea Wand, Christine Lasset, Dominique Stoppa‐Lyonnet, Muriel Belotti, Francesca Damiola, Laure Barjhoux, Sylvie Mazoyer, Mattias Van Heetvelde, Bruce Poppe, Kim De Leeneer, Kathleen Claes, Miguel de la Hoya, Vanesa García‐Barberán, Pedro Pérez Segura, Johanna I. Kiiski, Kristiina Aittomäki, Sofia Khan, Heli Nevanlinna, Christi J. van Asperen, Vaszko Tibor, Miklós Kásler, Edith Oláh, Judith Balmañà, Sara Gutiérrez‐Enríquez, Orland Dı́ez, Àlex Teulé, Á. Izquierdo, Esther Darder, Joan Brunet, Jesús Del Valle, Lídia Feliubadaló, Miquel Angel Pujana, Conxi Lázaro, Aðalgeir Arason, Bjarni A. Agnarsson, Oskar T. Johannsson, Rósa B. Barkardóttir, Elisa Alducci, Silvia Tognazzo, Marco Montagna, Manuel R. Teixeira, Pedro Pinto, Amanda B. Spurdle, Helene Holland, Jong Won Lee, Min Hyuk Lee, Jihyoun Lee, Sung-Won Kim, Eunyoung Kang, Zisun Kim, Priyanka Sharma, Timothy R. Rebbeck, Joseph Vijai, Mark E. Robson, Anne Lincoln, Jacob Musinsky, Pragna Gaddam, Yen Y. Tan, Andreas Berger, Christian F. Singer, Jennifer T. Loud, Mark H. Greene, Anna Marie Mulligan, Gord Glendon, Irene L. Andrulis, Amanda E. Toland, Leigha Senter, Anders Bojesen, Henriette Roed Nielsen, Anne‐Bine Skytte, Lone Sunde, Uffe Birk Jensen, Inge Søkilde Pedersen, Lotte Krogh, Torben A. Kruse, Maria A. Caligo, Sook-Yee Yoon, Soo‐Hwang Teo, Anna von Wachenfeldt, Dezheng Huo, Sarah M. Nielsen, Olufunmilayo I. Olopade, Katherine L. Nathanson, Susan M. Domchek, Christa Lorenchick, Rachel C. Jankowitz, Ian Campbell, Paul A. James, Gillian Mitchell, Nick Orr, Sue K. Park, Mads Thomassen, Kenneth Offit, Fergus J. Couch, Jacques Simard, Douglas F. Easton, Georgia Chenevix‐Trench, Rita K. Schmutzler, Antonis C. Antoniou, Laura Ottini

Bibliographic record

VenueJournal of Clinical Oncology · 2017
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsnot available
FundersNIH Office of the DirectorInstituto de Salud Carlos IIIEuropean Social FundMedical Research CouncilQIMR Berghofer Medical Research InstituteSchool of MedicineNational Institutes of HealthUniversitätsklinikum KölnKWF KankerbestrijdingFox Chase Cancer CenterMinistero dello Sviluppo EconomicoUniversità degli Studi di UdineRoyal Marsden NHS Foundation TrustFondazione Italiana per la Ricerca sul CancroHospices Civils de LyonNational Health and Medical Research CouncilDeutsche KrebshilfeMedizinische Universität WienMedizinischen Hochschule HannoverUniversitair Medisch Centrum GroningenCancer Council QueenslandLeids Universitair Medisch CentrumCentre Hospitalier Universitaire de QuébecMedical Center, University of PittsburghWestfälische Wilhelms-Universität MünsterCentre National de la Recherche ScientifiqueEuropean CommissionCanadian Institutes of Health ResearchLietuvos Mokslo TarybaPeter MacCallum Cancer CentreOdense UniversitetshospitalUniversitair Ziekenhuis GentAalborg UniversitetshospitalGentofte HospitalFondation ARC pour la Recherche sur le CancerIstituto Toscano TumoriHarvard T.H. Chan School of Public HealthHungarian Scientific Research FundUnicancerGeneral Secretariat for Research and TechnologyHáskóli ÍslandsLandspítali HáskólasjúkrahúsErasmus Medisch CentrumMinisterio de Economía y CompetitividadMinistero della SaluteUniversity of TorontoMcGill UniversityGeneralitat de CatalunyaNederlandse Organisatie voor Wetenschappelijk OnderzoekSoonchunhyang UniversityUniversiteit GentSapienza Università di RomaNational Breast Cancer FoundationNational Cancer InstituteSeoul National UniversityInstitut Claudius RegaudMinistério da Ciência, Tecnologia e InovaçãoOhio State UniversityUniversiteit LeidenCentre Léon BérardGovernment of CanadaMemorial Sloan-Kettering Cancer CenterIstituto Oncologico VenetoHelsingin YliopistoUniversité LavalRadboud Universitair Medisch CentrumUniversität WienRadboud UniversiteitCancer AustraliaUniversité de LyonFonds Wetenschappelijk OnderzoekHuntsman Cancer InstituteCancer Research UKAssociazione Italiana per la Ricerca sul CancroBeckman Research Institute, City of HopeFondation du cancer du sein du QuébecWellcome TrustDeutsches KrebsforschungszentrumCancer Research InstituteKansas Bioscience AuthorityDr. Ralph and Marian Falk Medical Research TrustInstitut BergoniéCancer Center, University of KansasCancerfondenRigshospitaletMinistère du Développement Économique, de l’Innovation et de l’ExportationFundación Mutua MadrileñaDavid F. and Margaret T. Grohne Family FoundationBreast Cancer Research FoundationUniversity of PittsburghJewish General HospitalNational Institute for Health and Care ResearchAarhus UniversitetshospitalAalborg UniversitetGenome CanadaCreighton UniversityInstitut Català de la SalutInstitut Gustave-RoussyUniversity of PennsylvaniaFundación CellexAarhus UniversitetCollege of Medicine, Seoul National UniversitySusan G. Komen for the Cure
KeywordsMedicineBreast cancerProstate cancerPolygenic risk scoreOncologyLifetime riskMutationInternal medicineProstateCancerGeneticsGeneSingle-nucleotide polymorphismGenotypeBiology

Abstract

fetched live from OpenAlex

Purpose BRCA1/2 mutations increase the risk of breast and prostate cancer in men. Common genetic variants modify cancer risks for female carriers of BRCA1/2 mutations. We investigated—for the first time to our knowledge—associations of common genetic variants with breast and prostate cancer risks for male carriers of BRCA1/ 2 mutations and implications for cancer risk prediction. Materials and Methods We genotyped 1,802 male carriers of BRCA1/2 mutations from the Consortium of Investigators of Modifiers of BRCA1/2 by using the custom Illumina OncoArray. We investigated the combined effects of established breast and prostate cancer susceptibility variants on cancer risks for male carriers of BRCA1/2 mutations by constructing weighted polygenic risk scores (PRSs) using published effect estimates as weights. Results In male carriers of BRCA1/2 mutations, PRS that was based on 88 female breast cancer susceptibility variants was associated with breast cancer risk (odds ratio per standard deviation of PRS, 1.36; 95% CI, 1.19 to 1.56; P = 8.6 × 10 −6 ). Similarly, PRS that was based on 103 prostate cancer susceptibility variants was associated with prostate cancer risk (odds ratio per SD of PRS, 1.56; 95% CI, 1.35 to 1.81; P = 3.2 × 10 −9 ). Large differences in absolute cancer risks were observed at the extremes of the PRS distribution. For example, prostate cancer risk by age 80 years at the 5th and 95th percentiles of the PRS varies from 7% to 26% for carriers of BRCA1 mutations and from 19% to 61% for carriers of BRCA2 mutations, respectively. Conclusion PRSs may provide informative cancer risk stratification for male carriers of BRCA1/2 mutations that might enable these men and their physicians to make informed decisions on the type and timing of breast and prostate cancer risk management.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.115
Threshold uncertainty score0.361

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.088
GPT teacher head0.430
Teacher spread0.342 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations181
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicBRCA gene mutations in cancerFrench-language works237,207